How to Get into Turkey's Medical Device Market?

Published Jan 17, 2013
Ankara, Turkey  - Despite the global economic crisis, Turkey has one of the most attractive economies due to its growing health care sector. As a result of this growth, the market for medial devices in Turkey is also growing. The 2010 figures for Turkey’s medical equipment and disposables/reusables market suggests a capacity exceeding $2 billion (US). Meanwhile, this capacity is expected to reach $3 billion (US) by 2015. This potential makes it more attractive to enter the Turkish medical device market. In recent years, the Ministry of Health of Turkey has been leading Health Transformation Reform. The transformation program changed the health system in Turkey. As a result of this change, Turkish medical device market regulations and market access also changed. The regulations changed to match EU countries. Reimbursement, however, is the fundamental driver of the market access of the Turkish medical devices market. In addition, new directions will change the medical device reimbursement system for reimbursement of medical devices in 2013. With these new directions, economic analysis is going to be mandatory for submitting reimbursement applications in Turkey. The article, “Medical Device Policies & Market Access in Turkey,” published in the November/December 2012 Issue of ISPOR CONNECTIONS (Vol.18 No 6), is a good resource to learn about the Turkish medical device market. An overview of the market access of medical devices in Turkey is mentioned in the study and new challenges for the medical device sector, like hospital unions and implementing DRG payments, is also discussed.

ISPOR CONNECTIONS (ISSN 1538-5108), the bimonthly news & technical journal of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR), strives to provide timely communications on methodological and health policy issues of interest to Society members.

International Society for Pharmacoeconomics and Outcomes Research (ISPOR) is a nonprofit, international, educational and scientific organization that strives to increase the efficiency, effectiveness, and fairness of health care resource use to improve health.

For more information:

Related Stories

Global Experts Introduce Strategic Action Plan to Accelerate Patient Access to Next-Generation DNA Sequencing in Oncology

Sep 27, 2022

Value & Outcomes Spotlight, the health economics and outcomes research (HEOR) news magazine of ISPOR, announced the publication of a supplement, “A Plan of Action: Accelerating Patient Access to Next-Generation Sequencing in Oncology,” that details the challenges in improving patient access to next-generation DNA sequencing and proposes a plan of action to improve access.

Alzheimer’s Disease: Modifying Value Frameworks to Evaluate Current and Emerging Interventions

Mar 15, 2021

Value & Outcomes Spotlight announced the publication of a special supplement exploring value assessment of new interventions in Alzheimer’s disease. The supplement, “Valuing Future Alzheimer’s Disease Treatments: The Need for a Holistic Approach,” was sponsored by Biogen and is based on a series of educational webinars produced by Biogen and ISPOR.

Virtual ISPOR Europe 2020 Live Conference Concluded

Nov 23, 2020

ISPOR announced that its Virtual ISPOR Europe 2020 conference, “Improving Health: Establishing Incentives and Sharing Value,” is now available on demand through 31 December 2020. ISPOR Europe is the leading European conference for health economics and outcomes research.
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on Update my browser now